Viktoza instructions for use
The drug is available in the form of a disposable pen - a syringe. Designed to lower blood sugar levels in patients with a history of type 2 diabetes. Viktoza is used in combination with diet and individually selected physical exercises, as well as in combination with other drugs to control the glycemic level.
Release form and composition
Substance liraglutid is considered an active active ingredient. Its content in 1 ml reaches 6 mg. One syringe - the pen has a volume of a medicine of 3 ml, which contain 18 mg of liraglutide. Auxiliary components are represented by propylene glycol, hydrochloric acid, phenol, hydrogen phosphate dihydrate sodium, water for injection.
Secondary cardboard packaging may contain 3, 2 or 1 syringe - a handle made of plastic. The kit also includes detailed instructions.
Indications for use
Viktoza is prescribed to control blood sugar levels in patients with type 2 diabetes. It can be combined with metformin or other means prescribed by the attending physician.
It is impossible to prescribe Viktoza for such conditions and diseases:
- increased sensitivity to the main active component, as well as to any of the auxiliary elements;
- breastfeeding period;
- diabetic ketoacidosis;
- liver failure;
- type 1 diabetes;
- malfunction of the urinary system;
- heart failure;
- age up to 18 years;
- paresis of the stomach;
- intestinal inflammatory diseases.
Caution is required in the treatment of Viktoza in patients with heart failure 1 - 2 classes, not pronounced lesions of the kidneys or liver, as well as in patients older than 75 years of age.
Dosing and Administration
Ease of use is to use the drug once for 24 hours. The injection is allowed to be carried out subcutaneously in the thigh, shoulder or abdomen. The injection does not depend on food intake. It is advisable to observe the intervals between the injections. The solution should not be administered intravenously and intramuscularly.
At the beginning of therapy, the dosage is 0.6 mg of liraglutide per 24 hours. At least after 7 days of use, the dose is increased to 1.2 mg per day. There is information that the effectiveness of treatment appears especially often when prescribing a dose in the range of 1.2-1.8 mg per 24 hours. A dose of 1.8 mg is also administered after 7 days of applying a dose of 1.2 mg. It is undesirable to exceed the daily dosage of 1.8 mg liraglutide.
Often Victoza is combined with metformin or other drugs. Proper dosing of these funds should be discussed further with your doctor.
Patients are periodically assigned to a blood test, especially with Victoza therapy in combination with other medications.
In old age, the dosage does not differ from the above. Only patients over 75 years of age need increased attention when treating with the drug.
In renal failure, which has a slight severity, dose adjustment is not needed. In case of kidney failure, severe victosis is contraindicated. Also, no remedy is prescribed for all stages of liver failure.
Till 18 years Viktoza not appointed. There is no data on its use in this age group.
Not used in the treatment of patients with type 1 diabetes and diabetic ketoacidosis. Data on the use of Viktoza in the treatment of patients with different severity of heart failure are missing. There is no information about side effects in people with intestinal inflammatory diseases and gastric paresis. These groups are contraindicated for Viktozy.
Therapy with this tool can cause short-term negative manifestations in the form of dyspeptic complications. There is a possibility of pancreatitis . Cases of pancreatitis have been reported in the acute stage. Its development is indicated by persistent pain of severe severity in the gastrointestinal tract. In this case, treatment with Viktosa immediately stop.
During trials, there were reports of malfunctions in the thyroid gland (changes in hormone tests, development of tumors, goiter, especially in people who had problems with this organ before therapy).
The likelihood of hypoglycemia increases with a combination of sulfonylurea and Viktoza derivatives. Requires adjustment of the dose of concomitant medications.
Data on the effects of Victoza on women who are carrying a pregnancy are not available. However, in animal studies, it was found that the drug has reproductive toxicity. During pregnancy, insulin therapy is recommended, Viktoza is contraindicated. If the pregnancy is only planned or the term is small, then Viktozy injections are prohibited. They need to stop immediately.
The penetration of liraglutide into the milk of lactating women is low, but during this period Viktoza is not prescribed.
Terms and conditions of storage
The storage term is 30 months. Storage is carried out only in the refrigerator at temperatures from 2 to 8 degrees. Must be kept away from children. Freezing is not allowed.
Currently there are no Victoza analogues.
Viktoza solution for injection 6mg / ml 3ml - 10000-11500 rubles.